Company / Operating Income per Share
Rein Therapeutics, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.01
FY2025
5-year range
-$6.09 / -$0.47
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 9 years, ranging from $-29.81 in FY2017 to $-0.47 in FY2021.
Based on SEC 10-K filings.
-3.01 in FY2025.
Improved from $-6.09 to $-3.01 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 9.8% year-over-year.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.01 | +9.8% |
| FY2024 | -$3.33 | +45.3% |
| FY2023 | -$6.09 | -3.6% |
| FY2022 | -$5.87 | -1155.6% |
| FY2021 | -$0.47 | +56.6% |
| FY2020 | -$1.08 | +50.2% |
| FY2019 | -$2.16 | -38.4% |
| FY2018 | -$1.56 | +94.8% |
| FY2017 | -$29.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026